Design, synthesis and anticonvulsant activity of the potent adenosine kinase inhibitor GP3269

Nucleosides and Nucleotides

Volumn 16, Issue 7-9, 1997, Pages 1013-1021

  Erion, Mark D ^a   Ugarkar, Bheemarao G ^a   DaRe, Jay ^a   Castellino, Angelo J ^a   Fujitaki, James M ^a   Dixon, Ross ^a   Appleman, James R ^a   Wiesner, James B ^a  

^a Gensia Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE KINASE INHIBITOR; ANTICONVULSIVE AGENT; GP 3269; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG HALF LIFE; DRUG METABOLISM; DRUG SYNTHESIS; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEIZURE;

ANIMALIA; CANIS FAMILIARIS; LATEOLABRAX JAPONICUS;

EID: 0030809882     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319708006124     Document Type: Conference Paper

References (21)

1. Williams, M. Neurochem. Int. 1989, 14, 249-264.
2. Dragunow, M.; Goddard, G.V.; Laverty, R. Epilepsia 1985, 26, 480-487.
3. Dragunow, M. in "Adenosine and Adenine Nucleotides as Regulators of Cellular Function", J.W. Phillis, Ed., CRC Press, Boca Raton, 1991, pp. 367-379.
4. Winn, H.R.; Welshe, J.E.; Rubio, R.; Berne, R.M. Circ. Res. 1980, 47, 568-577.
5. Dunwidde, T.V. in "Adenosine and Adenosine Receptors", Williams, M., Ed., Humana Press, Clifton, N.J., 1990, pp. 143-172.
6. Choi, D.W. Neuron 1988, 1, 623-634.
7. Jarvis, M.F.; Williams, M. in "Adenosine and Adenosine Receptors", Williams, M., Ed., Humana Press, Clifton, N.J., 1990, pp.423-474.
8. Ault, B.; Olney, M.A.; Joyner, J.L.; Boyer, C.E.; Notrica, M.A., Soronko, F.E.; Wang, C.M. Brain Res. 1987, 426, 93-102.
9. Zang,G.; Murray, T.F. Soc. Am. Soc.Pharmacol. Exp. Ther. 1991, 33, 196.
10. Burke, S.P.; Nadler, J.V. Neurochem. 1988, 51, 1541.
11. Erion, M.D. Ann. Rep. Med. Chem. 1993, 28, 295-304.
12. Browne, C.E.; Ugarkar, B.G.; Mullane, K.M.; Gruber, H.E.; Bullough, D.A.; Erion, M.D.; Castellino, A. 1992, EP 496617.
13. Zhang, G.; Franklin, P.H.; Murray, T.F. J. Exp. Pharm. Ther. 1993, 264, 1415.
14. Davies, L.P.; Jamieson, D.D.; Baird-Lambert, J.A.; Kazlauska, R. Biochem. Pharm. 1984, 33, 347-355.
15. Pudlo J.S.; Nassiri, M.R.; Kern, E.R.; Wotring, L.L.; Drach, J.C.; Townsend, L.B. J. Med. Chem. 1990, 33, 1984-1992.
16. Ramasamy, K.; Imamura, N.; Robins, R.; Revankar, G.R. Tet. Lett. 1987, 28, 5107-5110.
17. Wilcox, C.S.; Otoski, R.M. Tet. Lett. 1986, 27, 1011-1014.
18. Unrau, C.M.; Campbell, M.G.; Snieckus, V. Tet. Lett. 1992, 33, 2773-2776.
19. Wiesner, J.B.; Zimring, S.T.; Castellino, A.J.; Ugarkar, B.G. Shea, M.; Erion, M.D.; Foster, A.C. Epilepsia 1995, 36 (Suppl. 4), 86.
20. Shunk, C.H.; Lavigne, J.B.; Folkers, K. J. Am. Chem. Soc. 1955, 77, 2210-2212.
21. Yamada, Y.; Goto, H.; Ogasawara, N. Biochim. Biophys. Acta 1988, 660, 38-43.